![](https://pharma.industry-report.net/wp-content/uploads/2018/10/usfda.png.webp)
Aurobindo Pharma receives tentative approval from USFDA for Lacosamide
Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy […]
Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy […]
Copyright © 2025 | WordPress Theme by MH Themes